Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
*This tip was originally published in April 2025 and has since been updated to reflect recent changes. The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Brad Hart, MBA, MS, CPC, CPMA, COBGC; Stephen Bacak, DO, FACOG; Steve Rad MD, FACOG, SMFM Coding Committee Chair, Trisha... Continue Reading
In response to today’s White House press conference announcement, The Society for Maternal-Fetal Medicine (SMFM) reiterates its recommendation advising both physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM), the national organization representing high-risk pregnancy experts, reiterates its recommendation that all pregnant and breastfeeding people receive the COVID-19 vaccine, regardless of trimester. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) continues to advise physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
By: Adam K. Lewkowitz, MD, MPHS, and Emily S. Miller, MD, MPH On July 21, 2025, the Food and Drug Administration (FDA) convened a roundtable panelist discussion on the use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medication, in pregnancy. The FDA... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Robert Rossi, MD Katherine Kohari, MD Barbra Fisher, MD, PhD and Betzaida Martinez CPC, CPMA, COBGC, CPPM Background Multiple societies (AIUM, SMFM, ACOG, ACOOG, SDMS, SFP, and FHS) recommend performing a detailed fetal... Continue Reading
SMFM strongly supports the work of the U.S. Preventive Services Task Force (USPSTF) and urges HHS Secretary Robert F. Kennedy, Jr., to retain the current members and the integrity of this critical independent, volunteer group of experts. Continue Reading
By Brian K. Iriye, MD; Vanita D. Jain, MD; and Anthony C. Sciscione, DO What is DFTU and Why Is It Important? The Detailed First-Trimester Ultrasound (DFTU) is a high-resolution scan performed between weeks 12 and 13 of pregnancy to detect fetal structural anomalies.1 It is indicated for... Continue Reading
As experts in high-risk pregnancies, the Society for Maternal-Fetal Medicine (SMFM) and its members are alarmed by the unsubstantiated and inaccurate claims made by FDA panelists concerning maternal depression and the use of SSRI antidepressants during pregnancy. Continue Reading
AAP, ACP, APHA, IDSA, MPHA, SMFM, and a pregnant physician, filed suit in the U.S. District Court for the District of Massachusetts to defend vaccine policy, and to put an end to the Secretary’s assault on science, public health and evidence-based medicine. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is deeply disappointed in today’s final vote by the House of Representatives resulting in the passage of H.R. 1. The deep cuts to the Medicaid program contained in this legislation jeopardize the insurance coverage millions of... Continue Reading
